Search Results - "L. Salazar-Vizcaya"
-
1
On the potential of a short‐term intensive intervention to interrupt HCV transmission in HIV‐positive men who have sex with men: A mathematical modelling study
Published in Journal of viral hepatitis (01-01-2018)“…Summary Increasing access to direct‐acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection and decelerating the rise in high‐risk behaviour…”
Get full text
Journal Article -
2
Rapid decline of anti‐hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV‐infected men who have sex with men
Published in HIV medicine (01-07-2018)“…Objectives Following clearance of incident hepatitis C virus (HCV) infections, HCV antibody levels may decline, resulting in seroreversion. It is unclear to…”
Get full text
Journal Article -
3
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)
Published in Open forum infectious diseases (01-11-2023)“…Abstract Background After basic immunization with 2 mRNA SARS-CoV-2 vaccine doses, only a small proportion of patients who are severely immunocompromised…”
Get full text
Journal Article -
4
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy
Published in Clinical infectious diseases (11-09-2023)“…Abstract Background Integrase strand transfer inhibitors (INSTIs) have been associated with an increased risk for cardiovascular disease (CVD) events. We…”
Get full text
Journal Article -
5
Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study
Published in Clinical infectious diseases (19-07-2024)“…Abstract Background Advancements in access to antiretroviral therapy (ART) and human immunodeficiency virus (HIV) care have led to a decline in AIDS-related…”
Get full text
Journal Article -
6
Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide (TAF) in People With Human Immunodeficiency Virus (HIV)
Published in Clinical infectious diseases (09-07-2024)“…Abstract Background Antiretroviral therapy (ART)-related weight gain is of particular concern in people with HIV (PWH). Although weight gain was observed among…”
Get full text
Journal Article -
7
Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy
Published in The Journal of infectious diseases (16-10-2024)“…We evaluated long-term trajectories of circulating hepatitis B virus (HBV) RNA and hepatitis B core-related antigen (HBcrAg) in persons with and without…”
Get full text
Journal Article -
8
Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study
Published in The Journal of infectious diseases (16-08-2024)“…Abstract Background Factors influencing susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain to be resolved. Using data from…”
Get full text
Journal Article -
9
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection
Published in Journal of hepatology (01-05-2023)“…HBV coinfection is common among people living with HIV (PLWH) and is the most important cause of hepatocellular carcinoma (HCC). While risk prediction tools…”
Get full text
Journal Article -
10
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV
Published in Clinical pharmacology and therapeutics (01-06-2024)“…Long‐acting cabotegravir has been studied mainly in the stringent framework of clinical trials, which does not necessarily reflect the situation of people with…”
Get full text
Journal Article -
11
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study
Published in The Journal of infectious diseases (15-09-2023)“…Abstract Background Bone mineral density (BMD) loss may be accelerated in people with HIV (PLWH). It is unknown whether a polygenic risk score (PRS) is…”
Get full text
Journal Article -
12
Impact of hormonal therapy on HIV‐1 immune markers in cis women and gender minorities
Published in HIV medicine (01-10-2024)“…Background Although sex hormones are recognized to induce immune variations, the effect of hormonal therapy use on immunity is only poorly understood. Here, we…”
Get full text
Journal Article -
13
Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)
Published in BMJ open (23-09-2024)“…Prospective, multicentric observational cohort study in Switzerland investigating measures to prevent mother-to-child transmission in pregnant women with HIV…”
Get full text
Journal Article -
14
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland
Published in The Lancet regional health. Europe (01-01-2024)“…The efficacy and tolerability of long-acting cabotegravir and rilpivirine were demonstrated in Phase III trials. However, low concentrations combined with…”
Get full text
Journal Article -
15
External Validation of Serologic Scores for the Detection of Liver Steatosis Among People With HIV
Published in Open forum infectious diseases (01-09-2024)“…Abstract Background Fatty liver index (FLI) and hepatic steatosis index (HSI) are serologic scores used to detect liver steatosis. However, their diagnostic…”
Get full text
Journal Article -
16
Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19
Published in Open forum infectious diseases (01-08-2023)“…Abstract Despite decreased numbers of sexual partners, the COVID-19 pandemic had limited impact on the prevalence of attending private sex parties, traveling…”
Get full text
Journal Article -
17
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk
Published in Open forum infectious diseases (01-09-2024)“…Abstract The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found…”
Get full text
Journal Article -
18
Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods
Published in Cell reports methods (26-06-2023)“…While combination therapy completely suppresses HIV-1 replication in blood, functional virus persists in CD4+ T cell subsets in non-peripheral compartments…”
Get full text
Journal Article -
19
Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study
Published in The Lancet regional health. Europe (01-08-2023)“…Low rates of postnatal retention in HIV care and viral suppression have been reported in women living with HIV (WLWH) despite viral suppression at delivery. At…”
Get full text
Journal Article -
20
Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort studyResearch in context
Published in The Lancet regional health. Europe (01-08-2023)“…Background: Low rates of postnatal retention in HIV care and viral suppression have been reported in women living with HIV (WLWH) despite viral suppression at…”
Get full text
Journal Article